Woodline Partners LP - 30 Sep 2025 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: ALGS
Shares outstanding: 5,381,598 shares
Disclosed Ownership: 468,199 shares
Ownership: 8.7%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:15:45 UTC
Date of event: 30 Sep 2025
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	8.7%	468,199	468,199	0	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer